Corrigendum to: Should treatment of low-level rifampicin mono-resistant tuberculosis be different? (vol 23, 100241, 2021)

F. A. Gopie*, E. Commiesie, W. C. M. de Lange, D. van Soolingen, S. G. S. Vreden, G. de Vries

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    10 Downloads (Pure)
    Original languageEnglish
    Article number100245
    Number of pages1
    JournalJournal of Clinical Tuberculosis and Other Mycobacterial Diseases
    Volume24
    DOIs
    Publication statusPublished - Aug-2021

    Cite this